GenomeNet

Database: CarbBank
Entry: 1039 1040 1041 1042 8576 10507 11299 16334 16360 17654 17780 38020
LinkDB: 1039 1040 1041 1042 8576 10507 11299 16334 16360 17654 17780 38020
CC: CCSD:1039
AU: Koscielak J; Piasek A; Gorniak H; Gardas A; Gregor A
TI: Structures of fucose-containing glycolipids with H and B blood-group
    activity and of sialic acid and glucosamine-containing glycolipid of
    human erythrocyte membrane
CT: Eur J Biochem (1973) 37: 214-225 [PMID:4745728]
BS: (CN) human, (OT) erythrocyte
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
SB: Karlsson KA
DA: 22-04-1989
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:1040
AU: Hanfland P; Egge H
TI: Mass spectrometric analysis of permethylated glycosphingolipids II.
    Comparative studies on different blood-group active and related
    erythrocyte membrane glycosphingolipids
CT: Chem Phys Lipids (1976) 16: 201-214 [PMID:945136]
BS: (OT) erythrocyte
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
SB: Egge H
DA: 22-04-1989
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:1041
AU: Wherrett JR; Hakomori S
TI: Characterization of blood-group B glycolipid, accumulating in the
    pancreas of a patient with Fabry's disease
CT: J Biol Chem (1973) 248: 3046-3051 [PMID:4735571]
BS: (CN) human, (OT) pancreas, (disease) gangliosidosis
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
AM: GC-MS
SB: Karlsson KA
DA: 22-04-1989
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:1042
AU: Hanfland P
TI: Mass spectrometric analysis of permethylated glycosphingolipids I.
    Sequence analysis of two blood-group B active glycosphingolipids from
    human B erythrocyte membranes
CT: Chem Phys Lipids (1975) 15: 243-247 [PMID:1204134]
SC: B-I
BS: (CN) human, (OT) erythrocyte
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
SB: Levery S
DA: 22-04-1989
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:8576
AU: Hakomori SI
TI: Glycosphingolipids in cellular interaction, differentiation, and
    oncogenesis
CT: Ann Rev Biochem (1981) 50: 733-764 [PMID:7023369]
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
SB: Karlsson KA; Levery S
DA: 22-04-1989
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:10507
AU: Hanfland P
TI: Characterization of B and H blood-group active glycosphingolipids
    from human B erythrocyte membranes
CT: Chem Phys Lipids (1975) 15: 105-124 [PMID:812611]
SC: B-I
BS: (CN) human, (OT) erythrocyte
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
AM: GC-MS
SB: Doubet S
DA: 19-06-1992
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:11299
AU: Miura T; Handa S; Yamakawa T
TI: Specific inhibition of macrophage migration inhibition factor by
    fucosylated glycolipid RM
CT: J Biochem (1979) 86: 773-776 [PMID:389925]
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
SB: van Kuik A
DA: 04-01-1992
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:16334
AU: Lindberg AA; Brown JE; Stroemberg N; Westling-Ryd M; Schultz JE;
    Karlsson KA
TI: Identification of the carbohydrate receptor for Shiga toxin produced
    by Shigella dysenteriae type 1
CT: J Biol Chem (1987) 262: 1779-1785 [PMID:3543013]
SC: 17
BS: (CN) human, (OT) erythrocyte
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
SB: Kleen A
DA: 04-01-1992
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:16360
AU: Galili U; Basbaum CB; Shohet SB; Buehler J; Macher BA
TI: Identification of erythrocyte Gal.alpha.1-3Gal glycosphingolipids with a
    mouse monoclonal antibody, Gal-13
CT: J Biol Chem (1987) 262: 4683-4688 [PMID:2435715]
SC: 12
SC: BI
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
SB: Kleen A
DA: 04-01-1992
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:17654
AU: Bouhours JF; Richard C; Ruvoen N; Barreau N; Naulet J; Bouhours D
TI: Characterization of a polyclonal anti-Gal-.alpha.1-3Gal antibody from chicken
CT: Glycoconj J (1998) 15: 93-99 [PMID:9530963]
SC: B-6
BS: (CN) human, (OT) red blood cells
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
AM: ELISA
NT: CUII:1116
NT: Interaction with a chicken polyclonal antibody
SB: Ishizuka I
DA: 06-01-1999
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:17780
AU: Bouhours JF; Richard C; Ruvoen N; Barreau N; Naulet J; Bouhours D
TI: Characterization of a polyclonal anti-Gal-.alpha.1-3Gal antibody from chicken
CT: Glycoconj J (1998) 15: 93-99 [PMID:9530963]
SC: Gal-a3Lex-6
BS: (CN) pig, (OT) kidney
BS: (CN) rabbit (OT) red blood cells
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
AM: ELISA
NT: CUII:1119
NT: Interaction with a chicken polyclonal antibody
SB: Ishizuka I
DA: 06-01-1999
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
CC: CCSD:38020
AU: Gilboa-Garber N; Sudakevitz D; Sheffi M; Sela R; Levene C
TI: PA-I and PA-II lectin interactions with the ABO(H) and P blood group
    glycosphingolipid antigens may contribute to the broad spectrum adherence
    of Pseudomonas aeruginosa to human tissues in secondary infections
CT: Glycoconj J (1994) 11: 414-417 [PMID:7696845]
BS: (CN) human, (OT) erythrocyte
TN: IV3Gal.alpha.,IV2Fuc.alpha.-nLc4-Cer
AN: blood-group B antigen
MT: glycolipid
MT: glycosphingolipid
SB: Shough NJ
DA: 26-04-1995
FC: 5a7ef7fd
SI: CBank:16846
----------------
structure:

 a-D-Galp-(1-3)+
               |
          b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
               |
 a-L-Fucp-(1-2)+
================end of record
DBGET integrated database retrieval system